IN addition to the CoronaVac vaccine made by PT Sinovac, Sinopharm . vaccine It is also one of the Covid-19 vaccines developed and processed in China.
Regarding the effectiveness of the Sinopharm vaccine, there is a recent research study in Peru that examines the extent to which the Sinopharm Covid-19 vaccine is effective against Covid-19 infection.
Citing Reuters, Friday (13/8/2021) the research study in Peru showed that two doses of the Sinopharm vaccine had a 50.4 percent effectiveness in preventing Covid-19 infection in study participants, namely health workers in Peru, who are currently is experiencing a spike in cases due to the spread of the virus variant.
From the research published last week, it was also found that the third injection as a booster or booster could be considered, because the percentage of efficacy was not too high.
The research study conducted by scientists at Peru’s National Institutes of Health and two other research institutes was carried out using Sinopharm’s BBIBP-CorV vaccine involving approximately 400,000 frontline health workers, looking at data from February to June when Peru was being hit. second wave of infections triggered by Lambda and Gamma variants.
“The efficacy for preventing infection is not high and this is something to consider after the high percentage of the group of people who have already received the two doses. Moments when booster injections can be considered to optimize protection for frontline healthcare workers,” the study said.
However, it should be noted that the two full doses of Sinopharm vaccine reached a percentage of 94 percent effective in preventing deaths from Covid-19.
(DRM)
–
